Regeneration and Replacement of the Corneal Endothelium: Advances in Cell Therapy, Tissue Engineering, Molecular and Pharmacologic Strategies

Study limitation reported by the research below: “Regulatory status of cell injection therapy is jurisdiction-specific (approved in Japan; Phase 3 in the US as of publication); clinicians should verify local regulatory standing before referencing for practice.”